These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6745219)

  • 1. Michaelis-Menten kinetics of stiripentol in normal humans.
    Levy RH; Loiseau P; Guyot M; Blehaut HM; Tor J; Moreland TA
    Epilepsia; 1984 Aug; 25(4):486-91. PubMed ID: 6745219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stiripentol kinetics in epilepsy: nonlinearity and interactions.
    Levy RH; Loiseau P; Guyot M; Blehaut HM; Tor J; Moreland TA
    Clin Pharmacol Ther; 1984 Nov; 36(5):661-9. PubMed ID: 6488687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of stiripentol in normal man: evidence of nonlinearity.
    Levy RH; Lin HS; Blehaut HM; Tor JA
    J Clin Pharmacol; 1983; 23(11-12):523-33. PubMed ID: 6662977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of a new anticonvulsant, stiripentol, in the rhesus monkey.
    Lin HS; Levy RH
    Epilepsia; 1983 Dec; 24(6):692-703. PubMed ID: 6641646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study.
    Poisson M; Huguet F; Savattier A; Bakri-Logeais F; Narcisse G
    Arzneimittelforschung; 1984; 34(2):199-204. PubMed ID: 6326778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative anticonvulsant potency and pharmacokinetics of (+)-and (-)-enantiomers of stiripentol.
    Shen DD; Levy RH; Savitch JL; Boddy AV; Tombret F; Lepage F
    Epilepsy Res; 1992 Jun; 12(1):29-36. PubMed ID: 1526226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of stiripentol in the intravenous pentylenetetrazol infusion seizure model in the rat.
    Shen DD; Levy RH; Moor MJ; Savitch JL
    Epilepsy Res; 1990; 7(1):40-8. PubMed ID: 2292245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of stiripentol pharmacokinetics in healthy adult volunteers.
    Peigné S; Rey E; Le Guern ME; Dulac O; Chiron C; Pons G; Jullien V
    Epilepsy Res; 2014 Jul; 108(5):909-16. PubMed ID: 24725808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic study of 3H-stiripentol in rats (author's transl)].
    Pieri F; Wegmann R; Astoin J
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):5-10. PubMed ID: 7067724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaco-cellular enzymology of the mode of action of Stiripentol during cardiazolic epilepsia--IV. Cellular and tissular repartition of 3H-Stiripentol (author's transl)].
    Wegmann R; Ilies A; Aurousseau M; Patte F
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(1):51-60. PubMed ID: 476759
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants.
    Tran A; Rey E; Pons G; Rousseau M; d'Athis P; Olive G; Mather GG; Bishop FE; Wurden CJ; Labroo R; Trager WF; Kunze KL; Thummel KE; Vincent JC; Gillardin JM; Lepage F; Levy RH
    Clin Pharmacol Ther; 1997 Nov; 62(5):490-504. PubMed ID: 9390105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition by stiripentol of rat brain cytochrome P-450-mediated naphthalene hydroxylation.
    Mesnil M; Testa B; Jenner P
    Xenobiotica; 1988 Sep; 18(9):1097-106. PubMed ID: 3227707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo inhibition of rat brain cytochrome P-450 activity by stiripentol.
    Mesnil M; Testa B; Jenner P
    Biochem Pharmacol; 1988 Oct; 37(19):3619-22. PubMed ID: 3178875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and children.
    Ogungbenro K; Aarons L;
    Pharm Res; 2015 Jan; 32(1):144-57. PubMed ID: 25052507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective pharmacokinetics of stiripentol: an explanation for the development of tolerance to anticonvulsant effect.
    Arends RH; Zhang K; Levy RH; Baillie TA; Shen DD
    Epilepsy Res; 1994 Jun; 18(2):91-6. PubMed ID: 7957040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic fate of stiripentol in man.
    Moreland TA; Astoin J; Lepage F; Tombret F; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(6):654-62. PubMed ID: 2877822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.
    Levy RH; Rettenmeier AW; Anderson GD; Wilensky AJ; Friel PN; Baillie TA; Acheampong A; Tor J; Guyot M; Loiseau P
    Clin Pharmacol Ther; 1990 Sep; 48(3):225-35. PubMed ID: 2119269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.
    Cazali N; Tran A; Treluyer JM; Rey E; d'Athis P; Vincent J; Pons G
    Br J Clin Pharmacol; 2003 Nov; 56(5):526-36. PubMed ID: 14651727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stiripentol in acute/chronic efficacy tests in monkey model.
    Lockard JS; Levy RH; Rhodes PH; Moore DF
    Epilepsia; 1985; 26(6):704-12. PubMed ID: 4076073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain.
    Auvin S; Lecointe C; Dupuis N; Desnous B; Lebon S; Gressens P; Dournaud P
    Epilepsia; 2013 Dec; 54(12):2082-90. PubMed ID: 24117113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.